Gefitinib (IRESSA) versus vinorelbine in chemonaive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized Phase II study

被引：21

作者：

Crino, Lucio

Zatloukal, Petr

Reck, Martin

Pesek, Milos

Thomson, Joyce

Ford, Hugo

Hirsch, Fred

Duffield, Emma

Armour, Alison

Cullen, Michael

机构：

[1] Perugia Hosp, Dept Med Oncol, Perugia, Italy

[2] Charles Univ Prague, Dept Pneumol & Throac Surg, CR-11636 Prague 1, Czech Republic

[3] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany

[4] Charles Univ Prague, Med Fac Pilsen, Plzen, Czech Republic

[5] Birmingham Heartlands Hosp, Dept Oncol, Birmingham, W Midlands, England

[6] Univ Cambridge, Hosp NHS Trust, Oncol Dept, Cambridge, England

[7] Univ Colorado, Canc Ctr, Colorado City, CO USA

[8] Astra Zeneca, Macclesfield, Cheshire, England

[9] Queen Elizabeth Hosp, Dept Oncol, Birmingham, W Midlands, England

来源：

关键词：

D O I：

10.1097/01.JTO.0000283156.80991.51

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S341 / S341

页数：1